• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝苯地平对映异构体在 HPMC 和 HPMCP 无定形固体分散体中结晶速率的差异。

Differences in crystallization rate of nitrendipine enantiomers in amorphous solid dispersions with HPMC and HPMCP.

机构信息

Division of Drugs, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.

出版信息

Int J Pharm. 2011 Apr 4;407(1-2):111-8. doi: 10.1016/j.ijpharm.2011.01.035. Epub 2011 Jan 26.

DOI:10.1016/j.ijpharm.2011.01.035
PMID:21277962
Abstract

To clarify the contribution of drug-polymer interaction to the physical stability of amorphous solid dispersions, we studied the crystallization rates of nitrendipine (NTR) enantiomers with identical physicochemical properties in the presence of hydroxypropylmethylcellulose (HPMC), hydroxypropylmethylcellulose phthalate (HPMCP) and polyvinylpyrrolidone (PVP). The overall crystallization rate at 60°C and the nucleation rate at 50-70°C of (+)-NTR were lower than those of (-)-NTR in the presence of 10-20% HPMC or HPMCP. In contrast, similar crystallization profiles were observed for the NTR enantiomers in solid dispersions containing PVP. The similar glass transition temperatures for solid dispersions of (-)-NTR and (+)-NTR suggested that the molecular mobility of the amorphous matrix did not differ between the enantiomers. These results indicate that the interaction between the NTR enantiomers and HPMC or HPMCP is stereoselective, and that differences in the stereoselective interaction create differences in physical stability between (-)-NTR and (+)-NTR at 50-70°C. However, no difference in physical stability between the enantiomers was obvious at 40°C. Loss of the difference in physical stability between the NTR enantiomers suggests that the stereoselective interaction between NTR and the polymers may not contribute significantly to the physical stabilization of amorphous NTR at 40°C.

摘要

为了阐明药物-聚合物相互作用对无定形固体分散体物理稳定性的贡献,我们研究了具有相同物理化学性质的硝苯地平(NTR)对映异构体在羟丙基甲基纤维素(HPMC)、羟丙基甲基纤维素邻苯二甲酸酯(HPMCP)和聚乙烯吡咯烷酮(PVP)存在下的结晶速率。在 10-20%HPMC 或 HPMCP 存在下,(+)-NTR 的 60°C 总结晶速率和 50-70°C 的成核速率均低于(-)-NTR。相比之下,在含有 PVP 的固体分散体中,NTR 对映异构体表现出相似的结晶曲线。(-)-NTR 和(+)-NTR 固体分散体的相似玻璃化转变温度表明无定形基质的分子迁移率在对映异构体之间没有差异。这些结果表明,NTR 对映异构体与 HPMC 或 HPMCP 之间的相互作用具有立体选择性,并且立体选择性相互作用的差异导致(-)-NTR 和(+)-NTR 在 50-70°C 时物理稳定性存在差异。然而,在 40°C 时,对映异构体之间的物理稳定性差异不明显。NTR 对映异构体之间物理稳定性差异的丧失表明,NTR 与聚合物之间的立体选择性相互作用可能不会显著有助于 40°C 时无定形 NTR 的物理稳定化。

相似文献

1
Differences in crystallization rate of nitrendipine enantiomers in amorphous solid dispersions with HPMC and HPMCP.硝苯地平对映异构体在 HPMC 和 HPMCP 无定形固体分散体中结晶速率的差异。
Int J Pharm. 2011 Apr 4;407(1-2):111-8. doi: 10.1016/j.ijpharm.2011.01.035. Epub 2011 Jan 26.
2
Crystallization rate of amorphous nifedipine analogues unrelated to the glass transition temperature.与玻璃化转变温度无关的非晶态硝苯地平类似物的结晶速率。
Int J Pharm. 2007 May 4;336(1):191-5. doi: 10.1016/j.ijpharm.2006.11.052. Epub 2006 Nov 28.
3
Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.比较 HPMC 基聚合物作为热熔挤出法制备固体分散体载体的性能。
Int J Pharm. 2011 Oct 31;419(1-2):12-9. doi: 10.1016/j.ijpharm.2011.05.073. Epub 2011 Jul 22.
4
Investigation of drug-excipient interactions in lapatinib amorphous solid dispersions using solid-state NMR spectroscopy.使用固态核磁共振光谱法研究拉帕替尼无定形固体分散体中的药物-辅料相互作用。
Mol Pharm. 2015 Mar 2;12(3):857-66. doi: 10.1021/mp500692a. Epub 2015 Jan 28.
5
Preparation of a solid dispersion of felodipine using a solvent wetting method.采用溶剂湿润法制备非洛地平固体分散体。
Eur J Pharm Biopharm. 2006 Oct;64(2):200-5. doi: 10.1016/j.ejpb.2006.04.001. Epub 2006 Apr 27.
6
Mechanism of amorphous itraconazole stabilization in polymer solid dispersions: role of molecular mobility.聚合物固体分散体中非晶态伊曲康唑的稳定机制:分子流动性的作用。
Mol Pharm. 2014 Nov 3;11(11):4228-37. doi: 10.1021/mp5004515. Epub 2014 Oct 17.
7
Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64.洛哌丁胺及两个片段分子与聚合物PVP-K30和PVP-VA64形成的固体分散体中无定形态的物理稳定性。
Eur J Pharm Sci. 2005 Jun;25(2-3):313-20. doi: 10.1016/j.ejps.2005.03.012.
8
The stability of solid dispersions of felodipine in polyvinylpyrrolidone characterized by nanothermal analysis.纳米热分析表征的非洛地平聚乙烯吡咯烷酮固体分散体的稳定性。
Int J Pharm. 2011 Jul 29;414(1-2):210-7. doi: 10.1016/j.ijpharm.2011.05.037. Epub 2011 May 20.
9
Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.不同聚合物在有水分存在的情况下抑制无定形非洛地平结晶的能力。
Pharm Res. 2008 Apr;25(4):969-78. doi: 10.1007/s11095-007-9331-3. Epub 2007 May 23.
10
Development of fully amorphous dispersions of a low T(g) drug via co-spray drying with hydrophilic polymers.通过与亲水性聚合物共喷雾干燥开发低玻璃化转变温度(Tg)药物的完全无定形分散体。
Eur J Pharm Biopharm. 2012 Nov;82(3):572-9. doi: 10.1016/j.ejpb.2012.07.012. Epub 2012 Aug 24.

引用本文的文献

1
Accelerating Effects of Poloxamer and Its Structural Analogs on the Crystallization of Nitrendipine Polymorphs.泊洛沙姆及其结构类似物对尼群地平多晶型物结晶的加速作用
Pharmaceuticals (Basel). 2025 Jul 3;18(7):1000. doi: 10.3390/ph18071000.
2
Amorphous Solid Dispersion Formation for Enhanced Release Performance of Racemic and Enantiopure Praziquantel.无定形固体分散体形成增强消旋和对映纯吡喹酮的释放性能。
Mol Pharm. 2024 Oct 7;21(10):5285-5296. doi: 10.1021/acs.molpharmaceut.4c00711. Epub 2024 Sep 18.
3
Advances in the development of amorphous solid dispersions: The role of polymeric carriers.
非晶态固体分散体的发展进展:聚合物载体的作用。
Asian J Pharm Sci. 2023 Jul;18(4):100834. doi: 10.1016/j.ajps.2023.100834. Epub 2023 Aug 1.
4
Amorphous Solid Dispersion as Drug Delivery Vehicles in Cancer.无定形固体分散体作为癌症治疗中的药物递送载体
Polymers (Basel). 2023 Aug 11;15(16):3380. doi: 10.3390/polym15163380.
5
Carvedilol Precipitation Inhibition by the Incorporation of Polymeric Precipitation Inhibitors Using a Stable Amorphous Solid Dispersion Approach: Formulation, Characterization, and Evaluation.采用稳定无定形固体分散体方法通过加入聚合物沉淀抑制剂抑制卡维地洛沉淀:制剂、表征及评价
Polymers (Basel). 2022 Nov 17;14(22):4977. doi: 10.3390/polym14224977.
6
Amorphous Solid Dispersions: Role of the Polymer and Its Importance in Physical Stability and In Vitro Performance.无定形固体分散体:聚合物的作用及其在物理稳定性和体外性能方面的重要性。
Pharmaceutics. 2022 Aug 22;14(8):1747. doi: 10.3390/pharmaceutics14081747.
7
An Overview on Recent Patents and Technologies on Solid Dispersion.固体分散体的最新专利和技术概述。
Recent Pat Drug Deliv Formul. 2020;14(1):63-74. doi: 10.2174/1872211314666200117094406.
8
Effect of Carrier Lipophilicity and Preparation Method on the Properties of Andrographolide⁻Solid Dispersion.载体亲脂性及制备方法对穿心莲内酯固体分散体性质的影响
Pharmaceutics. 2019 Feb 10;11(2):74. doi: 10.3390/pharmaceutics11020074.
9
Development and evaluation of solid dispersion of spironolactone using fusion method.采用熔融法制备螺内酯固体分散体及其评价
Int J Pharm Investig. 2016 Jan-Mar;6(1):63-8. doi: 10.4103/2230-973X.176490.
10
Atorvastatin solid dispersion for bioavailability enhancement.用于提高生物利用度的阿托伐他汀固体分散体。
J Adv Pharm Technol Res. 2016 Jan-Mar;7(1):22-6. doi: 10.4103/2231-4040.169873.